Steve Wring

564 total citations · 1 hit paper
7 papers, 465 citations indexed

About

Steve Wring is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Rheumatology. According to data from OpenAlex, Steve Wring has authored 7 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 2 papers in Pediatrics, Perinatology and Child Health and 2 papers in Rheumatology. Recurrent topics in Steve Wring's work include Pharmacological Effects and Toxicity Studies (2 papers), HIV/AIDS drug development and treatment (2 papers) and Folate and B Vitamins Research (2 papers). Steve Wring is often cited by papers focused on Pharmacological Effects and Toxicity Studies (2 papers), HIV/AIDS drug development and treatment (2 papers) and Folate and B Vitamins Research (2 papers). Steve Wring collaborates with scholars based in United States, United Kingdom and Finland. Steve Wring's co-authors include Katyna Borroto–Esoda, Emily L. Larkin, N. Isham, Lisa Long, Mahmoud Ghannoum, Christopher Hager, Mauricio Retuerto, Iman Salem, Pranab K. Mukherjee and Jyotsna Chandra and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Hepatology and Pharmaceutical Research.

In The Last Decade

Steve Wring

7 papers receiving 451 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation

2017 316 citations Emily L. Larkin, Christopher Hager et al. Antimicrobial Agents and Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steve Wring United States	6	350	263	55	51	43	7	465
Tahziba Hussain India	15	231 0.7×	166 0.6×	133 2.4×	23 0.5×	33 0.8×	51	619
Sarah Whalley United Kingdom	13	234 0.7×	295 1.1×	37 0.7×	41 0.8×	45 1.0×	16	507
Carolyn E. Hughes United States	11	351 1.0×	261 1.0×	43 0.8×	26 0.5×	14 0.3×	16	519
T C Hardin United States	8	334 1.0×	256 1.0×	46 0.8×	58 1.1×	47 1.1×	15	537
Cuixiang Yu China	13	228 0.7×	137 0.5×	72 1.3×	14 0.3×	12 0.3×	19	383
Nerea Jauregizar Spain	10	231 0.7×	160 0.6×	42 0.8×	9 0.2×	15 0.3×	33	425
Ruth Van Daele Belgium	10	202 0.6×	177 0.7×	42 0.8×	16 0.3×	19 0.4×	20	404
S. Jevons United Kingdom	10	312 0.9×	259 1.0×	114 2.1×	32 0.6×	32 0.7×	21	630
Clara Rolland France	9	327 0.9×	65 0.2×	76 1.4×	22 0.4×	39 0.9×	18	557
J.B. Nikiema Burkina Faso	14	100 0.3×	128 0.5×	67 1.2×	23 0.5×	55 1.3×	28	458

Countries citing papers authored by Steve Wring

Since Specialization

Citations

This map shows the geographic impact of Steve Wring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Wring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Wring more than expected).

Fields of papers citing papers by Steve Wring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Wring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Wring. The network helps show where Steve Wring may publish in the future.

Co-authorship network of co-authors of Steve Wring

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Wring. A scholar is included among the top collaborators of Steve Wring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Wring. Steve Wring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Sitbon, Olivier, Andris Skride, Jeremy Feldman, et al.. (2024). Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial. The Lancet Respiratory Medicine. 12(11). 865–876. 5 indexed citations

2.

Larkin, Emily L., L. Long, N. Isham, et al.. (2019). A Novel 1,3-Beta- d -Glucan Inhibitor, Ibrexafungerp (Formerly SCY-078), Shows Potent Activity in the Lower pH Environment of Vulvovaginitis. Antimicrobial Agents and Chemotherapy. 63(5). 42 indexed citations

3.

Larkin, Emily L., Christopher Hager, Jyotsna Chandra, et al.. (2017). The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. Antimicrobial Agents and Chemotherapy. 61(5). 316 indexed citations breakdown →

4.

Moss, Darren, Paul L. Domanico, Seonghee Park, et al.. (2017). Simulating Intestinal Transporter and Enzyme Activity in a Physiologically Based Pharmacokinetic Model for Tenofovir Disoproxil Fumarate. Antimicrobial Agents and Chemotherapy. 61(7). 11 indexed citations

5.

Wring, Steve, et al.. (2016). Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate. Journal of Pharmaceutical Sciences. 106(3). 906–919. 21 indexed citations

6.

Wring, Steve, et al.. (2010). 676 IN VITRO MODELS FOR ASSESSING THE RELATIVE RISK OF HYPERBILIRUBINEMIA ASSOCIATED WITH CYCLOPHILIN INHIBITOR THERAPY. Journal of Hepatology. 52. S263–S263. 5 indexed citations

7.

Rautio, Jarkko, et al.. (2003). Midazolam Exhibits Characteristics of a Highly Permeable P-Glycoprotein Substrate. Pharmaceutical Research. 20(5). 757–764. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact